European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.
Articles
Efficacy and safety of PARP inhibitors in advanced or recurrent endometrial cancer patients: a systematic review and single arm meta-analysis
Efficacy and safety of PARP inhibitors in advanced or recurrent endometrial cancer patients: a systematic review and single arm meta-analysis
DOI: 10.22514/ejgo.2026.021
Abstract ( 185 ) PDF (1.7 MB) ( 136 ) Full Text
Real-world data on predictors of survival in patients with gynecological tumors following pelvic arterial embolization
Real-world data on predictors of survival in patients with gynecological tumors following pelvic arterial embolization
DOI: 10.22514/ejgo.2026.022
Abstract ( 176 ) PDF (7.81 MB) ( 144 ) Full Text
Incidence and clinical course of lymphoceles following pelvic sentinel lymph node removal in endometrial cancer
Incidence and clinical course of lymphoceles following pelvic sentinel lymph node removal in endometrial cancer
DOI: 10.22514/ejgo.2026.023
Abstract ( 178 ) PDF (302.01 kB) ( 137 ) Full Text
Mismatch repair status in endometrial cancer: detection with immunohistochemical markers and its relationship with clinical outcome
Mismatch repair status in endometrial cancer: detection with immunohistochemical markers and its relationship with clinical outcome
DOI: 10.22514/ejgo.2026.024
Abstract ( 170 ) PDF (3.02 MB) ( 107 ) Full Text
Comparative outcomes of MPPE and segmental rectosigmoid resection in cytoreductive surgery for advanced ovarian cancer
Comparative outcomes of MPPE and segmental rectosigmoid resection in cytoreductive surgery for advanced ovarian cancer
DOI: 10.22514/ejgo.2026.025
Abstract ( 167 ) PDF (494.3 kB) ( 127 ) Full Text
OATH trial: a phase II trial evaluating the combination of onapristone with anastrozole for women with hormone receptor positive endometrial cancer
OATH trial: a phase II trial evaluating the combination of onapristone with anastrozole for women with hormone receptor positive endometrial cancer
DOI: 10.22514/ejgo.2026.026
Abstract ( 189 ) PDF (1.07 MB) ( 103 ) Full Text
Sophoraflavanone G decreases the migratory ability of cancer cells by altering the cytokine profile of the environment in endometrial cancer and macrophage co-culture
Sophoraflavanone G decreases the migratory ability of cancer cells by altering the cytokine profile of the environment in endometrial cancer and macrophage co-culture
DOI: 10.22514/ejgo.2026.027
Abstract ( 197 ) PDF (3.27 MB) ( 137 ) Full Text
p53 protein expression, TP53 gene mutations, and in silico p53 activity as prognostic markers for ovarian cancer
p53 protein expression, TP53 gene mutations, and in silico p53 activity as prognostic markers for ovarian cancer
DOI: 10.22514/ejgo.2026.028
Abstract ( 191 ) PDF (2.33 MB) ( 124 ) Full Text
Breast cancer: is the current screening appropriate?The RISCAM study
Breast cancer: is the current screening appropriate?The RISCAM study
DOI: 10.22514/ejgo.2026.029
Abstract ( 197 ) PDF (4.61 MB) ( 113 ) Full Text
Enhanced recovery after surgery (ERAS) for laparoscopic hysterectomy in low-risk endometrial cancer: a randomized controlled trial
Enhanced recovery after surgery (ERAS) for laparoscopic hysterectomy in low-risk endometrial cancer: a randomized controlled trial
DOI: 10.22514/ejgo.2026.030
Abstract ( 163 ) PDF (850.2 kB) ( 142 ) Full Text
Clinicopathological significance of immunohistochemical expression of p53 and PTEN in endometrial carcinoma
Clinicopathological significance of immunohistochemical expression of p53 and PTEN in endometrial carcinoma
DOI: 10.22514/ejgo.2026.031
Abstract ( 169 ) PDF (1.97 MB) ( 109 ) Full Text
Successful treatment of primary non-gestational choriocarcinoma of the uterine cervix in a postmenopausal woman
Successful treatment of primary non-gestational choriocarcinoma of the uterine cervix in a postmenopausal woman
DOI: 10.22514/ejgo.2026.032
Abstract ( 200 ) PDF (2.07 MB) ( 113 ) Full Text
Disease-free survival following total pelvic exenteration in localized platinum-resistant recurrent ovarian clear cell carcinoma: a case report
Disease-free survival following total pelvic exenteration in localized platinum-resistant recurrent ovarian clear cell carcinoma: a case report
DOI: 10.22514/ejgo.2026.033
Abstract ( 200 ) PDF (1.78 MB) ( 132 ) Full Text
Eflapegrastim-induced large vessel vasculitis in patient treated with recurrent uterine leiomyosarcoma
Eflapegrastim-induced large vessel vasculitis in patient treated with recurrent uterine leiomyosarcoma
DOI: 10.22514/ejgo.2026.034
Abstract ( 169 ) PDF (721.42 kB) ( 144 ) Full Text
A case of complete uterine prolapse complicated by cervical squamous cell carcinoma likely unrelated to HPV
A case of complete uterine prolapse complicated by cervical squamous cell carcinoma likely unrelated to HPV
DOI: 10.22514/ejgo.2026.035
Abstract ( 177 ) PDF (624.53 kB) ( 138 ) Full Text
Correction: PRDM6 promoter methylation as a potential epigenetic biomarker in BRCA-associated ovarian cancer
Correction: PRDM6 promoter methylation as a potential epigenetic biomarker in BRCA-associated ovarian cancer
DOI: 10.22514/ejgo.2026.036
Abstract ( 186 ) PDF (267.85 kB) ( 145 ) Full Text
Correction: Subjective perceptions of breast cancer treatment experiences in women: a Q methodological approach
Correction: Subjective perceptions of breast cancer treatment experiences in women: a Q methodological approach
DOI: 10.22514/ejgo.2026.037
Abstract ( 174 ) PDF (254.07 kB) ( 114 ) Full Text
Correction: CpG methylation of the PAX1 promoter in exfoliated cervical cells: a potential cervical cancer screening model
Correction: CpG methylation of the PAX1 promoter in exfoliated cervical cells: a potential cervical cancer screening model
DOI: 10.22514/ejgo.2026.038
Abstract ( 211 ) PDF (247.35 kB) ( 113 ) Full Text
Correction: Three serum miRNAs as potential biomarkers for early diagnosis of cervical cancer
Correction: Three serum miRNAs as potential biomarkers for early diagnosis of cervical cancer
DOI: 10.22514/ejgo.2026.039
Abstract ( 183 ) PDF (235.85 kB) ( 128 ) Full Text
Correction: Prognostic value of Ki-67 in patients with ovarian cancer
Correction: Prognostic value of Ki-67 in patients with ovarian cancer
DOI: 10.22514/ejgo.2026.040
Abstract ( 191 ) PDF (227.38 kB) ( 126 ) Full Text
Correction: Ecliptae Herba extracts suppress cell proliferation and induce cell apoptosis of ovarian cancer cells by inactivating PI3K/AKT signaling pathway
Correction: Ecliptae Herba extracts suppress cell proliferation and induce cell apoptosis of ovarian cancer cells by inactivating PI3K/AKT signaling pathway
DOI: 10.22514/ejgo.2026.041
Abstract ( 163 ) PDF (231.26 kB) ( 102 ) Full Text
Correction: Cancer screening behaviors and health literacy levels of women aged 30 and over in the northwest Turkey
Correction: Cancer screening behaviors and health literacy levels of women aged 30 and over in the northwest Turkey
DOI: 10.22514/ejgo.2026.042
Abstract ( 172 ) PDF (274.24 kB) ( 126 ) Full Text
Correction: Taraxasterol stimulates apoptosis of BCa cells via restraining PI3K/AKT and epidermal growth factor receptor (EGFR)
Correction: Taraxasterol stimulates apoptosis of BCa cells via restraining PI3K/AKT and epidermal growth factor receptor (EGFR)
DOI: 10.22514/ejgo.2026.043
Abstract ( 200 ) PDF (236.13 kB) ( 114 ) Full Text
Correction: Investigating the relationship between breast cancer and the postmenopausal period: a systematic meta-analysis
Correction: Investigating the relationship between breast cancer and the postmenopausal period: a systematic meta-analysis
DOI: 10.22514/ejgo.2026.044
Abstract ( 199 ) PDF (226.62 kB) ( 135 ) Full Text
Correction: The cytotoxic, genotoxic and apoptotic effects of an adsorbent and anti‑oxidative vaginal gel on human cervical cancer cell (HeLa) lines
Correction: The cytotoxic, genotoxic and apoptotic effects of an adsorbent and anti‑oxidative vaginal gel on human cervical cancer cell (HeLa) lines
DOI: 10.22514/ejgo.2026.045
Abstract ( 179 ) PDF (218.13 kB) ( 146 ) Full Text
Correction: Predictive value of multimodal ultrasound imaging and BCL-2 expression levels in the outcome of neoadjuvant chemotherapy for breast cancer
Correction: Predictive value of multimodal ultrasound imaging and BCL-2 expression levels in the outcome of neoadjuvant chemotherapy for breast cancer
DOI: 10.22514/ejgo.2026.046
Abstract ( 203 ) PDF (252.29 kB) ( 138 ) Full Text
Correction: Efficacy and safety of anlotinib combined with chemotherapy in the treatment of metastatic triple negative breast cancer
Correction: Efficacy and safety of anlotinib combined with chemotherapy in the treatment of metastatic triple negative breast cancer
DOI: 10.22514/ejgo.2026.049
Abstract ( 174 ) PDF (252.66 kB) ( 125 ) Full Text
Correction: Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2
Correction: Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2
DOI: 10.22514/ejgo.2026.050
Abstract ( 198 ) PDF (231.66 kB) ( 147 ) Full Text
Correction: Targeting CENPN to inhibit breast cancer progression: insights into cell growth and aerobic glycolysis modulation
Correction: Targeting CENPN to inhibit breast cancer progression: insights into cell growth and aerobic glycolysis modulation
DOI: 10.22514/ejgo.2026.051
Abstract ( 205 ) PDF (224.21 kB) ( 133 ) Full Text
Correction: FOXK2 affects the motility of endometrial cancer cells by mediating ZEB1
Correction: FOXK2 affects the motility of endometrial cancer cells by mediating ZEB1
DOI: 10.22514/ejgo.2026.052
Abstract ( 162 ) PDF (227.38 kB) ( 143 ) Full Text
Published Ahead of Print
Special Issues
Contemporary surgical management of cervical cancer: minimally invasive surgery, de-escalation and personalized approaches
Keywords: Cervical cancer; Minimally invasive surgery; Robotic surgery; Fertility-sparing surgery; Personalized Surgical Treatment
Editor: Simone Ferrero, MD, PhD
Submission deadline: 30 June 2027
Recent advances in gynecological oncology surgery
Keywords: Endometrial cancer; Ovarian cancer; Gynecology oncology; Surgery; IA; Cervical cancer; Vulvar cancer
Editor: Dr. Stefano Restaino, MD, Dr. Martina Arcieri, MD, PhD
Submission deadline: 28 February 2027
Quality of Life in Gynecologic Malignancies
Keywords: Quality of life; Palliative care; Symptom management
Editor: Lori Spoozak, MD
Submission deadline: 30 April 2027
Endometrial Cancer and Fertility Preservation in the Denatality ERA
Keywords: Endometrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve
Editor: Dr. Giuseppe Gullo, MD, PhD, Dr. Alessandra Lopez, MD, Dr. Valentina Billone, MD, PhD St.
Submission deadline: 31 December 2025
Advances in Ovarian Cancer Research
Keywords: Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation
Editor: Basel Refky, MD
Submission deadline: 31 October 2025
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy
Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers
Editor: Sharad Ghamande, MD, David Mysona, MD
Submission deadline: 30 March 2022
Selected Papers from the 2021 AGOA Society
Keywords: Gynecology Oncology;Endometrial Cancer;Ovarian Cancer;Vulvar Cancer;Breast Cancer;Aragón
Editor: Laura Baquedano Mainar, MD
Submission deadline: 15 March 2022
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click "Review for EJGO" below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Join Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member's or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Editor-in-Chief
Dennis S. Chi, MD, FACOG, FACS
Dr. Chi is the incumbent of the Ronald O. Perelman Chair in Gynecologic Surgery, Deputy Chief of the Gynecology Service, and Head of Ovarian Cancer Surgery at Memorial Sloan Kettering Cancer Center (MSKCC). He has been a faculty member at MSKCC since graduating from fellowship there in 1997. From 2001-2014, he was Co-Director of Pelvic Reconstructive Surgery and the Director of both the Gynecologic Oncology Fellowship and the Pelvic Reconstruction Clinical Research Fellowship. He established the International Gynecologic Oncology Fellowship program at MSKCC and was the Director of the program from 2004-2014. In 2014, he established the section of ovarian cancer surgery (named “Team Ovary”), the first gynecologic oncology team in the United States dedicated to improving the surgical and survival outcomes of patients with ovarian cancer. Since that time, Team Ovary has authored dozens of peer-reviewed publications and overall his research has led to over 370 peer-reviewed publications mostly focusing on surgery for gynecologic cancers. He is an editor of multiple textbooks and the lead editor of one of the authoritative textbook in the field of gynecologic oncology, Principles and Practice of Gynecologic Oncology, 8th edition. In March 2024, he was given the Society of Gynecologic Oncology’s Lifetime Achievement Award at their annual meeting.


